PMID- 24700654 OWN - NLM STAT- MEDLINE DCOM- 20150219 LR - 20211021 IS - 1097-4644 (Electronic) IS - 0730-2312 (Print) IS - 0730-2312 (Linking) VI - 115 IP - 8 DP - 2014 Aug TI - Effect of age on regulation of human osteoclast differentiation. PG - 1412-9 LID - 10.1002/jcb.24792 [doi] AB - Human skeletal aging is characterized as a gradual loss of bone mass due to an excess of bone resorption not balanced by new bone formation. Using human marrow cells, we tested the hypothesis that there is an age-dependent increase in osteoclastogenesis due to intrinsic changes in regulatory factors [macrophage-colony stimulating factor (M-CSF), receptor activator of NF-kappaB ligand (RANKL), and osteoprotegerin (OPG)] and their receptors [c-fms and RANK]. In bone marrow cells (BMCs), c-fms (r = 0.61, P = 0.006) and RANK expression (r = 0.59, P = 0.008) were increased with age (27-82 years, n = 19). In vitro generation of osteoclasts was increased with age (r = 0.89, P = 0.007). In enriched marrow stromal cells (MSCs), constitutive expression of RANKL was increased with age (r = 0.41, P = 0.049) and expression of OPG was inversely correlated with age (r = -0.43, P = 0.039). Accordingly, there was an age-related increase in RANKL/OPG (r = 0.56, P = 0.005). These data indicate an age-related increase in human osteoclastogenesis that is associated with an intrinsic increase in expression of c-fms and RANK in osteoclast progenitors, and, in the supporting MSCs, an increase in pro-osteoclastogenic RANKL expression and a decrease in anti-osteoclastogenic OPG. These findings support the hypothesis that human marrow cells and their products can contribute to skeletal aging by increasing the generation of bone-resorbing osteoclasts. These findings help to explain underlying molecular mechanisms of progressive bone loss with advancing age in humans. CI - (c) 2014 Wiley Periodicals, Inc. FAU - Chung, Ping-Lin AU - Chung PL AD - Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. FAU - Zhou, Shuanhu AU - Zhou S FAU - Eslami, Behnam AU - Eslami B FAU - Shen, Longxiang AU - Shen L FAU - LeBoff, Meryl S AU - LeBoff MS FAU - Glowacki, Julie AU - Glowacki J LA - eng GR - R01 AG025015/AG/NIA NIH HHS/United States GR - R01 AG028114/AG/NIA NIH HHS/United States GR - AG028114/AG/NIA NIH HHS/United States GR - AG025015/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Osteoprotegerin) RN - 0 (RANK Ligand) RN - 0 (Receptor Activator of Nuclear Factor-kappa B) RN - 0 (TNFRSF11A protein, human) RN - 0 (TNFSF11 protein, human) RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) RN - EC 2.7.10.1 (Receptor, Macrophage Colony-Stimulating Factor) SB - IM MH - Aging/*metabolism/pathology MH - Bone Marrow Cells/metabolism MH - Bone Resorption/genetics/metabolism/pathology MH - Cell Differentiation/*genetics MH - Gene Expression Regulation, Developmental/*genetics MH - Humans MH - Macrophage Colony-Stimulating Factor/biosynthesis MH - Osteoclasts/*metabolism/pathology MH - Osteogenesis/genetics MH - Osteoprotegerin/biosynthesis MH - RANK Ligand/biosynthesis/metabolism MH - Receptor Activator of Nuclear Factor-kappa B/biosynthesis MH - Receptor, Macrophage Colony-Stimulating Factor/biosynthesis MH - Stromal Cells/metabolism PMC - PMC4096781 MID - NIHMS596893 OTO - NOTNLM OT - AGING OT - MARROW STROMAL CELL OT - OPG OT - OSTEOCLAST OT - RANKL EDAT- 2014/04/05 06:00 MHDA- 2015/02/20 06:00 PMCR- 2015/08/01 CRDT- 2014/04/05 06:00 PHST- 2014/02/14 00:00 [received] PHST- 2014/02/19 00:00 [accepted] PHST- 2014/04/05 06:00 [entrez] PHST- 2014/04/05 06:00 [pubmed] PHST- 2015/02/20 06:00 [medline] PHST- 2015/08/01 00:00 [pmc-release] AID - 10.1002/jcb.24792 [doi] PST - ppublish SO - J Cell Biochem. 2014 Aug;115(8):1412-9. doi: 10.1002/jcb.24792.